Position in RPRX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$229,830
New position
Shares Held
4,099
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#173
of 258 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026SAGESPRING WEALTH PARTNERS, LLC holds $3,585,996 across 9 Biotechnology names. RPRX ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,382 | $1,679,940 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
833 | $519,408 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
888 | $267,314 | |
| 4 | INCY |
Incyte Corp
|
2,037 | $230,914 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
4,099 | $229,830 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
907 | $218,559 | |
| 7 | INSM |
INSMED Inc
|
2,031 | $216,545 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
1,141 | $213,686 |
All Filings in RPRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $229,830 | 4,099 | Shares | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||